Evidence map›Paper›PMID 42232191›Full record

ArticleRSC advances2026

Iridium-Schiff base complex-based fluorimetric turn-off sensor and HPLC-DAD analytical approaches for quantitation of 8-hydroxy-2'-deoxyguanosine as an oxidative DNA damage biomarker in biofluids of healthy and diabetic subjects.

Hazim M Ali, Tamer H A Hasanin, Ahmed Hamad Alanazi, Emad Manni, Moamen S Refat, Azza H Rageh, Mohammed Gamal

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hazim M AliDepartment of Chemistry, College of Science, Jouf University P.O. Box 2014 Sakaka Aljouf Saudi Arabia hmali@ju.edu.sa.ORCID https://orcid.org/0000-0003-0781-0850
Tamer H A HasaninDepartment of Chemistry, College of Science, Jouf University P.O. Box 2014 Sakaka Aljouf Saudi Arabia hmali@ju.edu.sa.
Ahmed Hamad AlanaziDepartment of Chemistry, College of Science, Jouf University P.O. Box 2014 Sakaka Aljouf Saudi Arabia hmali@ju.edu.sa.
Emad ManniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University Saudi Arabia.
Moamen S RefatDepartment of Chemistry, College of Science, Taif University P.O. Box 11099 Taif 21944 Saudi Arabia.
Azza H RagehDepartment of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University Al-Madinah Al-Munawarah 30001 Saudi Arabia.
Mohammed GamalDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Beni-Suef University Alshaheed Shehata Ahmed Hegazy St. Beni-Suef 62574 Egypt mgamalm3000@yahoo.com.ORCID https://orcid.org/0000-0002-4674-6516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

8-Hydroxy-2'-deoxyguanosine (8-OHdG) is a well-established biomarker of oxidative DNA damage formed through reactive oxygen species-mediated oxidation of guanosine residues. It is widely recognized as a laboratory biomarker of oxidative DNA damage and has been associated with carcinogenic progression. In this study, a novel, rapid, and highly selective spectrofluorometric platform was developed based on quenching of the fluorescence of a newly synthesized iridium-Schiff base complex by 8-OHdG; an HPLC-DAD method was also developed for confirmatory quantification. The iridium-Schiff complex exhibited intrinsic green fluorescence at

Identifiers

PMID42232191
PMCPMC13223893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.